DEXTER SUSAN (Chief Technical Officer) purchased 42.3% of their position (10K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $7.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/15/2023ACC: 0001493152-23-021430
Officer· Chief Technical Officer
Since Apr 2020
+10K
Net shares
Net buyer
$7.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.70
Trade value
$7K
% of position
42.3%
6/14/2023
23.67K→33.67K
Total
Net shares
+10K
Net value
$7K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/14/2023 | P · Purchase | +10K | $0.70 | $7K | 42.3% | 23.67K | 33.67K |
| Total | +10K | $7K | ||||||
Derivative Transactions0
No derivative transactions reported